PGT Innovations Announces 100% Ownership Stake in Eco Enterprises, LLC
NORTH VENICE, Fla.–(BUSINESS WIRE)–PGT Innovations (NYSE: PGTI), a national leader in the premium window, door,…
Month: June 2023
Antares Capital Expands Coverage into Europe with Appointment of Sheila Brown
Strategic Addition Supports Firm’s Continued Growth Plans Across Liquid Credit and Direct Lending in Europe…
University of Phoenix Honored with 2023 PESC Award for Career-Minded Learning Best Practices
Award highlights university commitment to preparing and supporting working adult learners with career focused programs…
Experienced Biotech Executive and Deal Maker Joins Zephyr AI as Chief Business Officer
TYSONS, Va.–(BUSINESS WIRE)–Zephyr AI, Inc. (“Zephyr AI”), a company building novel transparent AI to address…
Ascendis Pharma Opens Compassionate Use Program for TransCon™ PTH (palopegteriparatide) in Germany
– Compassionate use enables treating physicians in Germany to request access to investigational TransCon PTH…
Ascendis Pharma Opens Compassionate Use Program for TransCon™ PTH (palopegteriparatide) in Germany
– Compassionate use enables treating physicians in Germany to request access to investigational TransCon PTH…
MDxHealth Announces its Extraordinary General Shareholders’ Meeting
NEWS RELEASE – REGULATED INFORMATION JUNE 5, 2023, 5:30 pm ET/ 23:30 CEST…
MDxHealth Announces its Extraordinary General Shareholders’ Meeting
NEWS RELEASE – REGULATED INFORMATION JUNE 5, 2023, 5:30 pm ET/ 23:30 CEST…
Coherus Announces Positive Final Overall Survival Results of JUPITER-02 Phase 3 Trial Evaluating Toripalimab in Nasopharyngeal Carcinoma
JUPITER-02 Final Overall Survival Analysis in Intent-To-Treat Population Presented at ASCO 2023 – Toripalimab plus…
Coherus Announces Positive Final Overall Survival Results of JUPITER-02 Phase 3 Trial Evaluating Toripalimab in Nasopharyngeal Carcinoma
JUPITER-02 Final Overall Survival Analysis in Intent-To-Treat Population Presented at ASCO 2023 – Toripalimab plus…
Telesis Bio Announces Closing of $28.0 Million Private Placement of Preferred Stock And Warrants to Purchase an Additional $46.2 Million of Common Stock
SAN DIEGO, June 05, 2023 (GLOBE NEWSWIRE) — Telesis Bio Inc. (NASDAQ: TBIO), a leader…
Telesis Bio Announces Closing of $28.0 Million Private Placement of Preferred Stock And Warrants to Purchase an Additional $46.2 Million of Common Stock
SAN DIEGO, June 05, 2023 (GLOBE NEWSWIRE) — Telesis Bio Inc. (NASDAQ: TBIO), a leader…
Motus GI Announces Appointment of Ravit Ram as Chief Financial Officer
Company completes corporate reorganization focused on reducing operating costs while supporting key value creation drivers,…
Motus GI Announces Appointment of Ravit Ram as Chief Financial Officer
Company completes corporate reorganization focused on reducing operating costs while supporting key value creation drivers,…
Cellectis Showcased Preclinical Data at an Oral Presentation and Two Poster Presentations at the 29th International Society for Cell & Gene Therapy (ISCT 2023) Annual Event
Preclinical data on UCART20x22, Cellectis’ first allogeneic dual CAR T-cell product candidate to treat B-NHL,…
Cellectis Showcased Preclinical Data at an Oral Presentation and Two Poster Presentations at the 29th International Society for Cell & Gene Therapy (ISCT 2023) Annual Event
Preclinical data on UCART20x22, Cellectis’ first allogeneic dual CAR T-cell product candidate to treat B-NHL,…
Atea Pharmaceuticals to Present at the Jefferies Healthcare Conference
BOSTON, June 05, 2023 (GLOBE NEWSWIRE) — Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage…
Atea Pharmaceuticals to Present at the Jefferies Healthcare Conference
BOSTON, June 05, 2023 (GLOBE NEWSWIRE) — Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage…
Vir Biotechnology to Participate in the 44th Annual Goldman Sachs Global Healthcare Conference
SAN FRANCISCO, June 05, 2023 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today announced…
Vir Biotechnology to Participate in the 44th Annual Goldman Sachs Global Healthcare Conference
SAN FRANCISCO, June 05, 2023 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today announced…